Poor targeting of therapeutics leading to severe adverse effects on normal tissues is
considered one of the obstacles in cancer therapy. To help overcome this, nanoscale drug …

Bioactive compounds represent a broad class of dietary metabolites derived from fruits and
vegetables, such as polyphenols, carotenoids and glucosinolates with potential for cancer …

Chitosan (Ch)-coated nanostructured lipid carriers (NLCs) have great potential for
transdermal delivery with high localization of chemotherapeutics in breast cancer. This study …

Lung cancer is one of the leading causes of death in both males and females, and it is the
first causes of cancer-related deaths. Chemotherapy, surgery and radiotherapy are …

Quercetin (QUE) is a flavonol that has recently received great attention from the research
community due to its important pharmacological properties. However, QUE's low solubility …

Epidermal growth factor receptor (EGFR) plays a key role in signal transduction pathways
associated with cell proliferation, growth, and survival. Its overexpression and aberrant …

Cancer remains a leading cause of death worldwide, necessitating the development of
innovative and more effective treatment strategies. Conventional cancer treatments often …

Cancer causes many deaths worldwide each year, especially due to tumor heterogeneity
leading to disease progression and treatment failure. Targeted treatment of heterogeneous …

Quercetin, a flavonoid, is a dietary component that has attracted the attention of dietitians
and medicinal chemists due to its anticancer potential. It is an antioxidant that has a …

Oral squamous cell carcinoma (OSCC) frequently carries high epidermal growth factor
receptor (EGFR) expression. Erlotinib, a small molecule tyrosine kinase inhibitor (TKI), is an …